Literature DB >> 16284289

Opposing effects of oestradiol and progesterone on intracellular pathways and activation processes in the oxidative stress induced activation of cultured rat hepatic stellate cells.

T Itagaki1, I Shimizu, X Cheng, Y Yuan, A Oshio, K Tamaki, H Fukuno, H Honda, Y Okamura, S Ito.   

Abstract

BACKGROUND: Oxidative stress, including the generation of reactive oxygen species (ROS), is involved in hepatofibrogenesis. The authors' previous studies have shown that oestradiol suppresses hepatic fibrosis in animal models and attenuates the activation of cultured rat hepatic stellate cells (HSCs), which possess oestrogen receptor subtype beta and are also activated by ROS. AIMS: To define the mechanisms by which female sex hormones play an antifibrogenic role in activated HSCs, the effects of oestradiol and progesterone on ROS generation processes and intracellular pathways, leading to the activation of HSCs undergoing oxidative stress, was examined.
METHODS: HSCs, isolated from rats, were cultured for 7 days with oestradiol or progesterone for 24 hours as pretreatment, and oxidative stress was then induced by exposure to low doses of hydrogen peroxide for another 24 hours.
RESULTS: Oestradiol inhibited ROS generation and antioxidant enzyme loss via the suppression of NADH/NADPH oxidase activity, and attenuated hydrogen peroxide induced transforming growth factor-beta1 (TGF-beta1) expression, HSC proliferation and transformation, and the activation of mitogen activated protein kinase (MAPK) pathways and transcription factors. Progesterone exerted a stimulatory effect through the progesterone receptor on the induction of ROS generation processes and intracellular pathways, resulting in TGF-beta1 expression and HSC activation, and fibrogenic effects were inhibited by oestradiol.
CONCLUSION: These findings show for the first time that oestradiol inhibits the activation of transcription factors by suppressing ROS generation processes and the MAPK pathways, and inactivates the downstream transcription processes involved in TGF-beta1 expression and HSC activation, whereas progesterone acts in opposition to the favourable effects of oestradiol and its effects are blocked by oestradiol.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16284289      PMCID: PMC1774809          DOI: 10.1136/gut.2005.053278

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  40 in total

1.  Selective activation of p38 MAPK cascade and mitotic arrest caused by low level oxidative stress.

Authors:  S Kurata
Journal:  J Biol Chem       Date:  2000-08-04       Impact factor: 5.157

2.  Development and validation of real-time quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro.

Authors:  J Winer; C K Jung; I Shackel; P M Williams
Journal:  Anal Biochem       Date:  1999-05-15       Impact factor: 3.365

3.  Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis c.

Authors:  T Poynard; V Ratziu; F Charlotte; Z Goodman; J McHutchison; J Albrecht
Journal:  J Hepatol       Date:  2001-05       Impact factor: 25.083

4.  The alternative oxidase lowers mitochondrial reactive oxygen production in plant cells.

Authors:  D P Maxwell; Y Wang; L McIntosh
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-06       Impact factor: 11.205

5.  Suppressive effects of estradiol on dimethylnitrosamine-induced fibrosis of the liver in rats.

Authors:  M Yasuda; I Shimizu; M Shiba; S Ito
Journal:  Hepatology       Date:  1999-03       Impact factor: 17.425

6.  Hepatic stellate cells contain the functional estrogen receptor beta but not the estrogen receptor alpha in male and female rats.

Authors:  Y Zhou; I Shimizu; G Lu; M Itonaga; Y Okamura; M Shono; H Honda; S Inoue; M Muramatsu; S Ito
Journal:  Biochem Biophys Res Commun       Date:  2001-09-07       Impact factor: 3.575

7.  Glutathione levels discriminate between oxidative stress and transforming growth factor-beta signaling in activated rat hepatic stellate cells.

Authors:  P J De Bleser; G Xu; K Rombouts; V Rogiers; A Geerts
Journal:  J Biol Chem       Date:  1999-11-26       Impact factor: 5.157

8.  Combined effects of estrogen and progesterone on the anterior cruciate ligament.

Authors:  W D Yu; V Panossian; J D Hatch; S H Liu; G A Finerman
Journal:  Clin Orthop Relat Res       Date:  2001-02       Impact factor: 4.176

9.  Effects of idoxifene and estradiol on NF-kappaB activation in cultured rat hepatocytes undergoing oxidative stress.

Authors:  T Omoya; I Shimizu; Y Zhou; Y Okamura; H Inoue; G Lu; M Itonaga; H Honda; M Nomura; S Ito
Journal:  Liver       Date:  2001-06

10.  Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1.

Authors:  R Schreck; P Rieber; P A Baeuerle
Journal:  EMBO J       Date:  1991-08       Impact factor: 11.598

View more
  46 in total

1.  A biomarker panel for non-alcoholic steatohepatitis (NASH) and NASH-related fibrosis.

Authors:  Zobair M Younossi; Sandra Page; Nila Rafiq; Aybike Birerdinc; Maria Stepanova; Noreen Hossain; Arian Afendy; Zahra Younoszai; Zachary Goodman; Ancha Baranova
Journal:  Obes Surg       Date:  2011-04       Impact factor: 4.129

2.  Hepatitis C virus regulates transforming growth factor beta1 production through the generation of reactive oxygen species in a nuclear factor kappaB-dependent manner.

Authors:  Wenyu Lin; Wei-Lun Tsai; Run-Xuan Shao; Guoyang Wu; Lee F Peng; Lydia L Barlow; Woo Jin Chung; Leiliang Zhang; Hong Zhao; Jae-Young Jang; Raymond T Chung
Journal:  Gastroenterology       Date:  2010-03-12       Impact factor: 22.682

3.  Gender and menopause impact severity of fibrosis among patients with nonalcoholic steatohepatitis.

Authors:  Ju Dong Yang; Manal F Abdelmalek; Herbert Pang; Cynthia D Guy; Alastair D Smith; Anna Mae Diehl; Ayako Suzuki
Journal:  Hepatology       Date:  2014-02-18       Impact factor: 17.425

Review 4.  Sex Differences in Nonalcoholic Fatty Liver Disease: State of the Art and Identification of Research Gaps.

Authors:  Amedeo Lonardo; Fabio Nascimbeni; Stefano Ballestri; DeLisa Fairweather; Sanda Win; Tin A Than; Manal F Abdelmalek; Ayako Suzuki
Journal:  Hepatology       Date:  2019-09-23       Impact factor: 17.425

Review 5.  Alcoholic liver injury: influence of gender and hormones.

Authors:  Patricia K Eagon
Journal:  World J Gastroenterol       Date:  2010-03-21       Impact factor: 5.742

6.  Raloxifene Ameliorates Liver Fibrosis of Nonalcoholic Steatohepatitis Induced by Choline-Deficient High-Fat Diet in Ovariectomized Mice.

Authors:  Fangqiong Luo; Masatoshi Ishigami; Koichi Achiwa; Yoji Ishizu; Teiji Kuzuya; Takashi Honda; Kazuhiko Hayashi; Tetsuya Ishikawa; Yoshiaki Katano; Hidemi Goto
Journal:  Dig Dis Sci       Date:  2015-04-14       Impact factor: 3.199

7.  Hepatoprotective effect and possible mechanism of phytoestrogen calycosin on carbon tetrachloride-induced liver fibrosis in mice.

Authors:  Mengmeng Zhang; Yaxin Wang; Guannan Zhu; Cheng Sun; Jiajia Wang
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2020-05-30       Impact factor: 3.000

8.  Associations of gender and a proxy of female menopausal status with histological features of drug-induced liver injury.

Authors:  Ayako Suzuki; Huiman Barnhart; Jiezhun Gu; Herbert L Bonkovsky; Hans L Tillmann; Robert J Fontana; David E Kleiner
Journal:  Liver Int       Date:  2017-03-02       Impact factor: 5.828

9.  Effects of estradiol and progesterone on the proinflammatory cytokine production by mononuclear cells from patients with chronic hepatitis C.

Authors:  Ying Yuan; Ichiro Shimizu; Mi Shen; Eriko Aoyagi; Hidetaka Takenaka; Tatuzo Itagaki; Mari Urata; Katsutaka Sannomiya; Nao Kohno; Katsuyoshi Tamaki; Masayuki Shono; Tetsuji Takayama
Journal:  World J Gastroenterol       Date:  2008-04-14       Impact factor: 5.742

Review 10.  Female hepatology: favorable role of estrogen in chronic liver disease with hepatitis B virus infection.

Authors:  Ichiro Shimizu; Nao Kohno; Katsuyoshi Tamaki; Masayuki Shono; Hui-Wei Huang; Jiang-Hong He; Deng-Fu Yao
Journal:  World J Gastroenterol       Date:  2007-08-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.